Adam Kneepkens, MD, joined the Department of Medicine in the Division of Hospital Medicine as an Instructor in July 2025. He was born and raised in Duluth, MN, before attending Saint Louis University, where he received a bachelor’s degree in political science and biology. Following this, he returned to Minnesota to receive his medical degree from the University of Minnesota Medical School in the Twin Cities. Kneepkens completed his internal medicine internship and residency training at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis prior to joining the Division of Hospital Medicine. He decided to stay at BJH/WashU following residency because of the cooperative culture and excellent patient care offered to all patients. His clinical and professional interests include medical student and resident education, quality improvement work, complex patient care coordination, resource utilization, and improving patient experience.
Education
- BA, Biology and Political Science: Saint Louis University, St. Louis, MO (2018)
- Doctor of Medicine: University of Minnesota Medical School, Minneapolis, MN (2022)
- Residency, Internal Medicine: Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO (2025)
Clinical Interests
Medical student and resident education, quality improvement, complex patient coordination, resource utilization, and improving patient experience
Publications
Shah P, White M, Sievert A, Conway A, Kneepkens A, Sayuk G, Lisker-Melman M, Elwing J. Semaglutide improves metabolic dysfunction-associated steatohepatitis: A 10-year retrospective study. JGH Open. 2024 Feb 22;8(2):e13037. doi: 10.1002/jgh3.13037. PMID: 38389719; PMCID: PMC10883239.
Reilkoff R, Shaker S, Kahat D, Gu K, Kneepkens A, Hatch R, Worthington E, Miller Z, Wacker D, & Simmons K. (2020, May). End of Life Opportunities Identified as Largest Opportunity for Improvement Sepsis Associated Deaths. American Journal of Respiratory and Critical Care Medicine — ATS Abstract Issue, 201(09), A6023.
Presentations
Kneepkens A, Bradley J, Karachunski P, Wang S. (April 2021) “Acute descending paralysis and respiratory distress in a child: myasthenia gravis vs wound botulism” Presented at American Academy of Neurology annual conference 2021. Virtual conference (Due to Covid-19).
Reilkoff R, Shaker S, Kahat D, Gu K, Kneepkens A, Hatch R, Worthington E, Miller Z, Wacker D. (May 2020). “End of Life Opportunities Identified as Largest Opportunity for Improvement Sepsis Associated Deaths” Accepted at 2020 American Thoracic Society International Conference, Philadelphia, Pennsylvania. (Virtual due to Covid-19)
Kneepkens A, Gupta K, and Sharma V. (April 2020). “Can extremely low birth weight infants achieve optimal growth on an exclusive human milk diet?” Presented at University of PRESS 2020. Minneapolis, MN. Poster Presentation.
Hatch R, Kneepkens A, Gu K, Kahat D, Reilkoff R. (February 2020). “Evaluating outcomes and
preventability of sepsis associated deaths using a novel chart review tool.” Presented at UMN Medical School Longitudinal Project Conference, Minneapolis, MN. Poster Presentation.
Kneepkens A, Gupta K, and Sharma V. (October 2019). “Use of exclusive human milk-based fortification and its effects on the growth of extreme low birth weight infants.” Presented at Vermont Oxford Network Annual Quality Congress, Chicago, Illinois. Poster Presentation.